Decreased levels of ADAMTS-13 and increased VWF:ADAMTS-13 ratio, as well as higher FVIII levels in our patient group vs. controls, indicate a significant prothrombotic risk factor in neonates with CHD. This evidence concerns the gene ADAMTS13 and coronary artery disorder.